|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.00 GBX | -0.68% |
|
0.00% | +14.06% |
| Feb. 06 | Hargreave Hale AIM asset value falls after "eventful" first quarter | AN |
| Jan. 15 | TruFin lifts outlook, Abingdon reports revenue gain | AN |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 40.26M | -5.3% | -7.63% | - | - | -3.03x | |
| 118M | - | -294.89% | - | - | - | |
| 1.06B | 4.06% | 4.08% | 6.96% | 2.56% | 1.47x | |
| 236M | 7.68% | 11.17% | 4.15% | 1.84% | 2.45x | |
| 979M | 13.96% | 24.35% | 76.29% | 13.06% | 2.31x | |
| 242M | -23.46% | -22.25% | -11.16% | -7.57% | - | |
| 279M | 17.44% | 20.89% | 9.8% | 6.41% | 1.35x | |
| 49.25M | 36.5% | 47.28% | 21.58% | 16.98% | -1.02x | |
| 965M | -29.45% | 2.98% | - | - | - | |
| 38.43M | 9.72% | 18.26% | 14.1% | - | 0.26x | |
| 55.81M | -31.04% | -16.98% | -25.55% | -18.55% | -19.02x | |
| 53.42M | 22.27% | 32.58% | 30.1% | 36.97% | - | |
| 41.03M | 0.58% | 0.6% | 5.11% | - | -7.48x | |
| Average | 320M | 1.91% | -13.81% | 13.14% | 6.46% | -2.52x | |
| Weighted average by Cap. | 285M | 6.12% | -185.52% | 15.73% | 4.36% | 1.35x |
- Stock Market
- Equities
- DXRX Stock
- Sector Diaceutics PLC
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
